[go: up one dir, main page]

ES2167251B1 - Nuevos disacaridos con accion antiartrosica. - Google Patents

Nuevos disacaridos con accion antiartrosica.

Info

Publication number
ES2167251B1
ES2167251B1 ES200001741A ES200001741A ES2167251B1 ES 2167251 B1 ES2167251 B1 ES 2167251B1 ES 200001741 A ES200001741 A ES 200001741A ES 200001741 A ES200001741 A ES 200001741A ES 2167251 B1 ES2167251 B1 ES 2167251B1
Authority
ES
Spain
Prior art keywords
hydrogen
group
coch3
so3m
so3h
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200001741A
Other languages
English (en)
Other versions
ES2167251A1 (es
Inventor
Pahi Francisco J Vila
Salgado Francesc Flores
Roura Ramon Rubi
Pastor Narcis Arnau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioiberica SA
Original Assignee
Bioiberica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200001741A priority Critical patent/ES2167251B1/es
Application filed by Bioiberica SA filed Critical Bioiberica SA
Priority to ES01947467T priority patent/ES2267788T3/es
Priority to CA002415752A priority patent/CA2415752C/en
Priority to EP01947467A priority patent/EP1300411B1/en
Priority to US10/332,505 priority patent/US6680304B2/en
Priority to PT01947467T priority patent/PT1300411E/pt
Priority to AU2001269139A priority patent/AU2001269139A1/en
Priority to DE60122156T priority patent/DE60122156T2/de
Priority to AT01947467T priority patent/ATE335752T1/de
Priority to PCT/ES2001/000265 priority patent/WO2002008239A1/es
Priority to DK01947467T priority patent/DK1300411T3/da
Publication of ES2167251A1 publication Critical patent/ES2167251A1/es
Application granted granted Critical
Publication of ES2167251B1 publication Critical patent/ES2167251B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/033—Uronic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"Nuevos disacáridos con acción antiartrósica". La presente invención se refiere a nuevos disacáridos de fórmula (I), **Figura** donde R{sup,1} se selecciona del grupo constituido por hidrógeno, (C{sub,1}-C{sub,4})-alquilo lineal o ramificado, fenilalquilo de menos de diez átomos de carbono y -COCH{sub,3}; R{sup,2} se selecciona del grupo constituido por hidrógeno, -COCH{sub,3} y SO{sub,3}M; R{sub,3) se selecciona del grupo constituido por hidrógeno, (C{sub,1}-C{sub,4}-alquilo lineal o ramificado, fenilalquilo de menos de diez átomos, -COCH{sub,3} y -COPh, siendo Ph fenilo; G se escoge entre -COOR{sup,4} y -COOM, seleccionándose R{sup,4} del grupo constituido por hidrógeno, (C{sub,1}-C{sub,2}-alquilo y arilalquilo de menos de dieciséis átomos de carbono; A se selecciona del grupo constituida por hidrógeno, -SO{sub,3}H, -SO{sub,3}M y -COCH{sub,3}; B se selecciona del grupo constituido por hidrógeno, -SO{sub,3}H, SO{sub,3}M y -COCH{sub,3}; en donde necesariamente o A o B son o bien -SO{sub,3}H, o bien -SO{sub,3}M, y siendo M es un catión orgánico o metálico. Dichos compuestos pueden ser utilizados como antiartrósicos, antiinflamatorios o para controlar la coagulación sanguínea.
ES200001741A 2000-07-13 2000-07-13 Nuevos disacaridos con accion antiartrosica. Expired - Fee Related ES2167251B1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ES200001741A ES2167251B1 (es) 2000-07-13 2000-07-13 Nuevos disacaridos con accion antiartrosica.
AT01947467T ATE335752T1 (de) 2000-07-13 2001-07-05 Neue disaccharide mit anti-arthritischer wirkung
EP01947467A EP1300411B1 (en) 2000-07-13 2001-07-05 Novel disaccharides with anti-arthritic action
US10/332,505 US6680304B2 (en) 2000-07-13 2001-07-05 Disaccharides with anti-arthrosic properties
PT01947467T PT1300411E (pt) 2000-07-13 2001-07-05 Novos dissacaráridos
AU2001269139A AU2001269139A1 (en) 2000-07-13 2001-07-05 Novel disaccharides with anti-arthritic action
ES01947467T ES2267788T3 (es) 2000-07-13 2001-07-05 Nuevos disacaridos con accion antiartrosica.
CA002415752A CA2415752C (en) 2000-07-13 2001-07-05 Novel disaccharides with anti-arthritic action
PCT/ES2001/000265 WO2002008239A1 (es) 2000-07-13 2001-07-05 Nuevos disacaridos con accion antiartrosica
DK01947467T DK1300411T3 (da) 2000-07-13 2001-07-05 Nye disaccharider med anti-arthrose egenskaber
DE60122156T DE60122156T2 (de) 2000-07-13 2001-07-05 Neue disaccharide mit anti-arthritischer wirkung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200001741A ES2167251B1 (es) 2000-07-13 2000-07-13 Nuevos disacaridos con accion antiartrosica.

Publications (2)

Publication Number Publication Date
ES2167251A1 ES2167251A1 (es) 2002-05-01
ES2167251B1 true ES2167251B1 (es) 2003-09-16

Family

ID=8494247

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200001741A Expired - Fee Related ES2167251B1 (es) 2000-07-13 2000-07-13 Nuevos disacaridos con accion antiartrosica.
ES01947467T Expired - Lifetime ES2267788T3 (es) 2000-07-13 2001-07-05 Nuevos disacaridos con accion antiartrosica.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES01947467T Expired - Lifetime ES2267788T3 (es) 2000-07-13 2001-07-05 Nuevos disacaridos con accion antiartrosica.

Country Status (10)

Country Link
US (1) US6680304B2 (es)
EP (1) EP1300411B1 (es)
AT (1) ATE335752T1 (es)
AU (1) AU2001269139A1 (es)
CA (1) CA2415752C (es)
DE (1) DE60122156T2 (es)
DK (1) DK1300411T3 (es)
ES (2) ES2167251B1 (es)
PT (1) PT1300411E (es)
WO (1) WO2002008239A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070082851A1 (en) * 2003-11-24 2007-04-12 Optimer Pharmaceuticals Inc. Treatment of a condition in a mammal with administration of Compounds and Methods of Use
WO2005118609A2 (en) * 2004-05-26 2005-12-15 California Institute Of Technology Small molecule stimulators of neuronal growth
ES2327480B1 (es) * 2007-06-15 2010-08-10 Bioiberica, S.A. "disacaridos para el tratamiento de tendones, ligamentos y huesos".
US8912149B1 (en) 2007-11-28 2014-12-16 California Institute Of Technology Glycosaminoglycan mimetics
ES2364683B1 (es) * 2009-12-29 2012-08-08 Bioibérica S.A. Disacáridos sulfatados para el tratamiento de enfermedades neurodegenerativas y/o neurovasculares.
JP2014500863A (ja) * 2010-10-29 2014-01-16 オプコ ヘルス インコーポレイテッド エラスターゼ関連障害を治療するための高硫酸化二糖
US9770461B2 (en) 2013-08-02 2017-09-26 California Institute Of Technology Tailored glycopolymers as anticoagulant heparin mimetics
US10227370B2 (en) 2013-08-02 2019-03-12 California Institute Of Technology Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity
ES2684097B1 (es) 2017-03-29 2019-07-04 Bioiberica S A U Disacáridos sulfatados para el tratamiento del dolor neuropático

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
WO1993009766A1 (en) * 1991-11-15 1993-05-27 Arthro Research And Development Corporation Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
FR2789587B1 (fr) * 1999-02-11 2003-01-24 Inst Nat Sante Rech Med Moyens pour la regulation de la differenciation hematopoietique
FR2792319B1 (fr) * 1999-04-14 2001-07-06 Pf Medicament Procede de preparation de monosulfate de 4 ou 6 disaccharides, leur utilisation en cosmetique et en tant que medicament notamment pour le traitement des maladies du collagene

Also Published As

Publication number Publication date
AU2001269139A1 (en) 2002-02-05
ES2167251A1 (es) 2002-05-01
US20030181400A1 (en) 2003-09-25
CA2415752C (en) 2009-09-15
EP1300411A1 (en) 2003-04-09
CA2415752A1 (en) 2003-01-10
WO2002008239A1 (es) 2002-01-31
US6680304B2 (en) 2004-01-20
EP1300411B1 (en) 2006-08-09
PT1300411E (pt) 2006-12-29
ATE335752T1 (de) 2006-09-15
DK1300411T3 (da) 2006-12-04
ES2267788T3 (es) 2007-03-16
DE60122156T2 (de) 2007-08-23
DE60122156D1 (de) 2006-09-21

Similar Documents

Publication Publication Date Title
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
DE69331414D1 (de) Depsipeptide, herstellung und anwendung
DE60231901D1 (de) Dna-synthesepromotoren, mit dna-polymerase assoziierte faktoren und nutzung davon
DK0699204T3 (da) Anvendelse af indolocarbazolderivater til behandling af en patologisk tilstand i prostata
BR0113180A (pt) Composto de acilacetonitrila, processo para sua preparação e miticida contendo o mesmo
HUP9903836A2 (hu) Új eljárás Cox-2 inhibítor hatású fenil-szubsztituált 2(5H)-furanonok előállítására
ATE260269T1 (de) Substituierte 4h-chromene und ähnliche verbindungen als kaspasis aktivatoren und apoptosis induktoren und deren verwendung
ES2167251B1 (es) Nuevos disacaridos con accion antiartrosica.
WO2001079187A8 (en) Substituted 1,4-thiazepine and analogs and their use as activators of caspases
DK1447400T3 (da) Bicyklisk forbindelse
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
EP1392683A4 (en) SUBSTITUTED 4H-CHROMENS AND ANALOGS AS ACTIVATORS OF GASPASES AND INDUCTORS OF APOPTOSIS, AND THEIR USE
DE69104593D1 (de) Herstellung und Verwendung von N-Jodopropargyl-oxycarbonylaminosäure-Estern als antimicrobielle Mittel.
CA2261032A1 (en) Dibenzodihydropyridinecarboxylic esters and their use in chemiluminescent assay methods
DE50209545D1 (de) Flüssigkristallines medium
ATE453610T1 (de) Antimikrobiell wirksame 4-methyl-4-aryl-2- pentanole, deren herstellung und verwendung
BR0211652A (pt) Processo para produção de composto de piridina
ES8301972A1 (es) Procedimiento para la obtencion de n-oxidos de compuestos den-oxaciclil-alquil-piperidil-diaza
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
DE69904818D1 (de) Thienodipyridinderivate, ihre herstellung und verwendung
NO984597L (no) Amino- og hydroksysubstituerte trifenyl-s-triaziner som stabilisatorer
DE69306296D1 (de) Cyclohexanderivate und diese enthaltende flüssigkristalline Zusammensetzung
ATE268177T1 (de) Substituierte 1-(piperidin-4-yl)-3-(aryl)- isothioharnstoffe , ihre herstellung und therapeutische verwendung
GR3031390T3 (en) Fluoropropene compound, an insecticide containing the same and an intermediate for production thereof
WO2002002098A3 (en) Antibacterial method and composition with phenolic compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2167251B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100315